Conflicting Reports on Darya Shipilova’s Death
A 28-year-old laboratory technician in Russia has died, triggering a dispute between local authorities and international health experts over the cause of the fatality. Darya Shipilova, an employee at the anti-plague institute in the city of Irkutsk, passed away on October 2, two days after falling ill at work, according to reports from Russian media.
Rospotrebnadzor, Russia’s federal health watchdog, stated that Shipilova died from “pneumonia of unknown aetiology.” The agency explicitly denied that any laboratory accidents occurred at the facility and rejected claims that the death was linked to plague. Russian officials also informed the World Health Organization (WHO) that no cases of the dangerous disease had been recorded in Irkutsk.
However, the official narrative has faced scrutiny. Alexey Tsydenov, the head of the neighboring Buryatia region, initially posted on social media that Shipilova had died of plague. He later edited the post to suggest she had “possibly” died of the disease. These conflicting accounts have left many questions unanswered regarding the exact circumstances of her illness and death.
Understanding the Pneumonic Plague Threat
The bacterium Yersinia pestis causes plague, the same pathogen responsible for the medieval bubonic plague. While the bubonic form is spread by flea bites and causes swollen lymph nodes, the pneumonic form affects the lungs. Pneumonic plague is significantly more dangerous because it can spread between people through respiratory droplets and carries a higher mortality rate.
Reports regarding how Shipilova contracted the illness vary. Some media outlets suggest she may have been infected after returning from Thailand, while others point to a potential laboratory accident involving a broken test tube. Rospotrebnadzor has dismissed the laboratory accident theory entirely.
Dr. Malick Gibani of Imperial College London noted that plague is not a relic of the past. He explained that a few hundred cases are reported globally each year, primarily in restricted geographic areas such as Madagascar and the Democratic Republic of the Congo, with occasional cases in the western United States and Central Asia.
Treatment for plague typically involves antibiotics such as fluoroquinolones and aminoglycosides, which are effective if administered early, according to Dr. Simon Clarke of the University of Reading. However, Professor Brendan Wren of the London School of Hygiene & Tropical Medicine warned that multi-antibiotic-resistant strains are emerging. If the laboratory was working with such a strain, treatment options could be severely limited.
Global Health Response and Biosecurity Concerns
In response to the incident, authorities have placed nearly 200 individuals who may have had contact with Shipilova under medical observation. Quarantines have been imposed in several hospitals in the region. Professor Alice Hughes of the University of Melbourne highlighted that the incubation period for pneumonic plague is short, typically one to three days, and noted that no one has yet shown symptoms.
The WHO has assessed the risk as moderate to low for Irkutsk, low for the Russian Federation, and very low for the wider European region. Christian Lindmeier, a spokesperson for the UN health agency, emphasized that the risk to the general public remains low.
Despite the low immediate risk, experts are calling for greater transparency. Dr. Zania Stamataki of the University of Birmingham stressed that while laboratory-acquired infections are rare due to strict containment protocols, they are not impossible. She argued that a full account of what happened is essential for global health security.
Professor Ian Jones of the University of Reading described the case as a rare lab accident unlikely to spread further. However, Dr. Clarke cautioned that until more details emerge, it is difficult to determine if this is an isolated occupational exposure or evidence of wider transmission. Gibani added that the incident highlights the need for continued investment in biosecurity and the development of better diagnostics and vaccines.
Source: The Guardian
